Skip to main content
Livermore
Livermore
ZHEN

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
676
Value
$421.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026676$421.5K<0.1%−458−40.4%ReducedHolders
Q1 20261,134$876.5K<0.1%+26+2.3%AddedHolders
Q4 20251,108$855.5K<0.1%+223+25.2%AddedHolders
Q3 2025885$497.6K<0.1%+446+101.6%AddedHolders
Q2 2025439$230.5K<0.1%−112−20.3%ReducedHolders
Q1 2025551$349.5K<0.1%+41+8.0%AddedHolders
Q4 2024510$363.3K<0.1%+29+6.0%AddedHolders
Q3 2024481$505.6K<0.1%−23−4.6%ReducedHolders
Q2 2024504$529.7K<0.1%+71+16.4%AddedHolders
Q1 2024433$423.0K<0.1%−46−9.6%ReducedHolders
Q4 2023479$420.7K<0.1%+17+3.7%AddedHolders
Q3 2023462$380.2K<0.1%−17−3.5%ReducedHolders
Q2 2023479$344.2K<0.1%+25+5.5%AddedHolders
Q1 2023454$373.0K<0.1%+128+39.3%AddedHolders
Q4 2022326$235.2K<0.1%+27+9.0%AddedHolders
Q3 2022299$206.0K<0.1%00.0%UnchangedHolders
Q2 2022299$177.0K<0.1%00.0%UnchangedHolders
Q1 2022299$209.0K<0.1%00.0%UnchangedHolders
Q4 2021299$189.0K<0.1%+217+264.6%AddedHolders
Q3 202182$50.0K<0.1%00.0%UnchangedHolders
Q2 202182$46.0K<0.1%−22−21.2%ReducedHolders
Q1 2021104$49.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.